Skip to main content
logo
Gin Hwa Biotech Incorporation (TPEX:7806)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
62.60
-0.20 (-0.32%)
At close: Sep 24, 2026

TPEX:7806 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
535.88538.65435.08403.56139.44
Revenue Growth
5.39%23.80%7.81%189.41%-
Gross Profit
143.22163.77138.19151.0649.87
Operating Income
64.7791.8584.11103.0732.97
Net Income
55.775.3366.7582.3829.61
Earnings Per Share
1.982.902.874.092.19
EPS Growth
-35.83%0.99%-29.84%86.89%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
74.71117.65116.5161.9241.37
Total Debt
224.34231.15207.77227.2576.24
Net Cash (Debt)
-149.63-113.49-91.26-165.32-34.87
Net Cash Growth
-----
Net Cash Per Share
-5.33-4.37-3.92-8.20-2.57

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
127.278.7970.5179.42107.61
Capital Expenditures
-315.25-313.45-111.19-255.21-26.75
Free Cash Flow
-188.05-234.66-40.68-175.880.87
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
26.73%30.40%31.76%37.43%35.77%
Operating Margin
12.09%17.05%19.33%25.54%23.65%
Pretax Margin
12.94%17.67%18.78%25.45%22.60%
Profit Margin
10.39%13.98%15.34%20.41%21.23%
FCF Margin
-35.09%-43.56%-9.35%-43.56%57.99%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
0.9520.9520.9520.4760.571
Dividend Per Share Growth
0%0%100.00%-16.66%-
Dividend Yield
1.52%1.37%1.40%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
31.5723.5326.63--
PS Ratio
3.773.294.09--